Human Health Innovation

Latest Articles on Human Health

With a pipeline of around 80 clinical and pre-clinical projects, and the potential to deliver up to 20 new therapy approvals over the next six years, we continue our track record of long-term innovation-led performance.

Our Innovation Strategy: how we approach research and development

An illustration of cells in a lighter green outline and a dark green background.

Human Health Innovation

Our Innovation Strategy: how we approach research and development

Disease never rests. So neither do we. Learn about how we are driving innovation in research and development, with the patient at the core of everything with do.

Digital innovation: “Our digital pipeline is only growing”

An illustration of a laptop outlined in light green on a dark green background.

Human Health Innovation

Digital innovation: “Our digital pipeline is only growing”

BRASS, a software advancing patient safety and developed fully in-house, has been sold. This is proof: our digital innovations are in demand.

“Rapid progress towards clinical candidates”

The rise of drug-resistant pathogens is a real threat.

Human Health Innovation

“Rapid progress towards clinical candidates”

Michel Pairet, Member of the Board of Managing Directors, explains why Boehringer Ingelheim expands its commitment to fighting drug resistant infections with a new joint venture.